Related references
Note: Only part of the references are listed.Organ-specific management and supportive care in chronic graft-versus-host disease
Fiona L. Dignan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Diagnosis and management of chronic graft-versus-host disease
Fiona L. Dignan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease
Laurie A. Milner et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
Daniel Wolff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study
Vinod K. Prasad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility
Y. Wang et al.
BONE MARROW TRANSPLANTATION (2011)
Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD
A. Rager et al.
BONE MARROW TRANSPLANTATION (2011)
Long term outcome of patients with steroid-refractory acute intestinal graft versus host disease after treatment with pentostatin
Stefan A. Klein et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids
Joseph Pidala et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial
Jose A. Perez-Simon et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Safety and Utility of Liver Biopsy After Pediatric Hematopoietic Stem Cell Transplantation
Benjamin Oshrine et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions
Hee Jin Byun et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Basiliximab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease After Unmanipulated HLA-Mismatched/Haploidentical Hematopoietic Stem Cell Transplantation
J. Z. Wang et al.
TRANSPLANTATION PROCEEDINGS (2011)
PROCHYMAL IMPROVES RESPONSE RATES IN PATIENTS WITH STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE (SR-GVHD) INVOLVING THE LIVER AND GUT: RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER PHASE III TRIAL IN GVHD
P. J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
D. Hoda et al.
BONE MARROW TRANSPLANTATION (2010)
Intra-arterial Methylprednisolone Infusion in Treatment-Resistant Graft-Versus-Host Disease
Joshua L. Weintraub et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
Chie Onishi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin
Sophie Paczesny et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients
Cesare Perotti et al.
TRANSFUSION (2010)
Nonabsorbable Corticosteroids Use in the Treatment of Gastrointestinal Graft-versus-Host Disease
Rami B. Ibrahim et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study
Carmen Martinez et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Successful Treatment of Severe Acute Intestinal Graft-versus-Host Resistant to Systemic and Topical Steroids with Alemtuzumab
Marc Schnitzler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease
Joseph Pidala et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease
Partow Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease
Daniel R. Couriel et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
Marco Mielcarek et al.
BLOOD (2009)
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
Amin M. Alousi et al.
BLOOD (2009)
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
T. Furlong et al.
BONE MARROW TRANSPLANTATION (2009)
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127-T regulatory cells
Piotr Trzonkowski et al.
CLINICAL IMMUNOLOGY (2009)
Improved Survival and Preserved Antiviral Responses After Combination Therapy With Daclizumab and Infliximab in Steroid-refractory Graft-Versus-Host Disease
Kanchan Rao et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Rapamycin for Refractory Acute Graft-Versus-Host Disease
David Ghez et al.
TRANSPLANTATION (2009)
Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: Rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies
William A. Ross et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
David Gomez-Almaguer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses
Helen Karlsson et al.
BLOOD (2008)
Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD
P. Perfetti et al.
BONE MARROW TRANSPLANTATION (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Severe Hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver
Hanaa Zidan et al.
PEDIATRIC BLOOD & CANCER (2008)
Clinical molecular imaging in intestinal graft-versus-host disease:: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography
Matthias Stelljes et al.
BLOOD (2008)
Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children
J. Inagaki et al.
BONE MARROW TRANSPLANTATION (2008)
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
John E. Levine et al.
BLOOD (2008)
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease
David M. Hockenbery et al.
BLOOD (2007)
Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
Alessandro Busca et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease
Pierre Bordigoni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease
Jose Luis Pinana et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Rituximab responsive refractory acute graft-versus-host disease
R. Kamble et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Extracorporeal photopheresis: A focus on apoptosis and cytokines
J. Bladon et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2006)
Treatment of acute graft-versus-host disease with prednisolone:: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin
Maria Teresa Van Lint et al.
BLOOD (2006)
Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist
VAM Funke et al.
BONE MARROW TRANSPLANTATION (2006)
The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation
FM Foss
SEMINARS IN HEMATOLOGY (2006)
Role of skin biopsy to confirm suspected acute graft-vs-host disease - Results of decision analysis
BF Firoz et al.
ARCHIVES OF DERMATOLOGY (2006)
Potential mechanisms of photopheresis in hematopoietic stem cell transplantation
D Peritt
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Technology Insight: ECP for the treatment of GvHD - can we offer selective immune control without generalized immunosuppression?
Scott R. Marshall
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease
A Takami et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
M Krejci et al.
ANNALS OF HEMATOLOGY (2005)
Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver
RF Duarte et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation:: Retrospective analysis and comparison with other interleukin-2 receptor antibodies
JO Bay et al.
TRANSPLANTATION (2005)
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease
JP Uberti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems:: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study
JY Cahn et al.
BLOOD (2005)
Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease
M Schmidt-Hieber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal Graft-versus-Host disease
RV Iyer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
XJ Huang et al.
BONE MARROW TRANSPLANTATION (2005)
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept
D Wolff et al.
BONE MARROW TRANSPLANTATION (2005)
Pentostatin in steroid-refractory acute graft-versus-host disease
J Bolaños-Meade et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Diverse effects of infliximab and etanercept on T lymphocytes
J Sieper et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease
PJ Shaughnessy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis
R Srinivasan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial
SJ Lee et al.
BLOOD (2004)
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
VT Ho et al.
BLOOD (2004)
Successful use of Campath-1H in the treatment of steroid refractory liver GvHD
F Wandroo et al.
BONE MARROW TRANSPLANTATION (2004)
Tumor necrosis factor-α blockade for the treatment of acute GVHD
D Couriel et al.
BLOOD (2004)
ABC of burns - Initial management of a major burn: II - assessment and resuscitation
S Hettiaratchy et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Alemtuzumab can successfully treat steroid-refractory acute graft-versus-host disease (aGVHD)
AM Carella et al.
BONE MARROW TRANSPLANTATION (2004)
Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients:: a cohort study
FM Marty et al.
BLOOD (2003)
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease
S Kulkarni et al.
BONE MARROW TRANSPLANTATION (2003)
Immunobiology of acute graft-versus-host disease
P Reddy et al.
BLOOD REVIEWS (2003)
Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
G Massenkeil et al.
BONE MARROW TRANSPLANTATION (2002)
Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion
G Akpek et al.
BLOOD (2002)
Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease
M Cruz-Correa et al.
ENDOSCOPY (2002)
Extracorporeal photochemotherapy for the treatment of graft-versus-host disease
R Dall'Amico et al.
THERAPEUTIC APHERESIS (2002)
Early Antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease
ML MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems
ML MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment
S Arai et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease
AI Benito et al.
TRANSPLANTATION (2001)
Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: an international practice survey
B Hsu et al.
BONE MARROW TRANSPLANTATION (2001)
Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody
G Kobbe et al.
BONE MARROW TRANSPLANTATION (2001)
Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients:: Four years of experience
N Basara et al.
TRANSPLANTATION PROCEEDINGS (2001)
Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation
N Fujii et al.
BONE MARROW TRANSPLANTATION (2001)
Acute graft-vs-host disease: Pathobiology and management
H Goker et al.
EXPERIMENTAL HEMATOLOGY (2001)
The CD52 antigen and development of the CAMPATH antibodies
G Hale
CYTOTHERAPY (2001)
Chronic graft-versus-host disease of the liver: Presentation as an acute hepatitis
SI Strasser et al.
HEPATOLOGY (2000)
Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages
MK Majumdar et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities
T Furlong et al.
BONE MARROW TRANSPLANTATION (2000)
Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation
YW Zhou et al.
ARCHIVES OF DERMATOLOGY (2000)
Mycophenolate mofetil and its mechanisms of action
AC Allison et al.
IMMUNOPHARMACOLOGY (2000)
A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease
L Cragg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
